Wang et al.60conducted a prognostic meta-analysis in nasopharyngeal carcinoma patients and identified a worse response to anti-PD1 and anti-CTLA4 treatment, as well as chemotherapy, in a subgroup characterized by stromal activation, low HLA family expression, and immune checkpoints. Here, CTLA4 is linked to nasopharyngeal carcinoma.